Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort

OBJECT: To ascertain the treatment effect of concurrent chemotherapy (CCT) in stage II‐III nasopharyngeal carcinoma (NPC) patients with different Epstein‐Barr virus (EBV) DNA level in intensity‐modulated radiotherapy (IMRT) era. METHODS: A total of 2742 patients diagnosed with stage II‐III NPC were...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xue‐Song, Chen, Wen‐Hui, Liu, Sai‐Lan, Liang, Yu‐Jing, Chen, Qiu‐Yan, Guo, Shan‐Shan, Wen, Yue‐Feng, Liu, Li‐Ting, Xie, Hao‐Jun, Tang, Qing‐Nan, Li, Xiao‐Yun, Yan, Jin‐Jie, Mai, Hai‐Qiang, Tang, Lin‐Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675745/
https://www.ncbi.nlm.nih.gov/pubmed/31210417
http://dx.doi.org/10.1002/cam4.2343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675745/
https://www.ncbi.nlm.nih.gov/pubmed/31210417
http://dx.doi.org/10.1002/cam4.2343

Ejemplares similares